Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Assessing and Treating Pain Heidi K. White, MD, MHS, MEd, CMD Speaker Disclosures Dr. White has no relevant financial relationships. Learning Objectives By the end of the session, participants will be able to: • Recognize categories and components of pain • Routinely utilize pain assessment techniques • Describe ways to assess and manage pain in patients with cognitive impairment. • Identify indications for specific approaches to pain management. • Identify potential resources to help manage pain. • Evaluate and reassess the effectiveness and adverse consequences (e.g., sedation, respiratory suppression, constipation) of pain interventions in accordance with patient goals and preferences. Pain Management Case Study Mr. S has been admitted after a hospitalization for pneumonia with a new diagnosis of metastatic lung cancer prior to this he had lived in the nursing home due to disability stemming from severe COPD. The nurses tell you they think he is depressed. When you go to visit Mr. S he forces a smile but appears tentative in his movements and grimaces when he coughs. When you ask about pain he shakes his head no. You reframe the question and use the term discomfort. He finally tells you that all of this is part of ‘getting old.’ Besides, he did not live a good life and God is ‘paying him back’. Difficulties in post-acute/long-term care… • Multiple concurrent illnesses • Under-reporting of symptoms • Expect pain with aging • Do not want to bother their physician • Do not want to be viewed as a “bad” patient • • • • Do not think their pain can be alleviated Pain means serious illness or death is near Fear diagnostic tests Fear addiction • Cognitive impairment • Poorly validated pain-assessment instruments Pain effects… • Physical – Sleep disturbance – Impaired ambulation deconditioning fall risk – Anorexia and malnutrition • Psychological – Depression • Social-role loss, isolation, economic burden • Spiritual-punishment?, harbinger of death Pain pathophysiology • Nociceptive Pain – Tissue injury stimulates specialized pain receptors – Somatic pain—skin, muscle bone, soft tissue • Trauma, inflammation, neoplastic infiltration – Visceral pain—internal organs and cavities • Distention, ischemia, inflammation • Neuropathic Pain – Abnormal function of the central or peripheral nervous system – Degeneration, compression, inflammation, ischemia, metabolic derangements, toxin, trauma – Descriptors: burning, shooting, and tingling – Signs: heightened sensitivity to non-painful stimuli and exaggerated sensitivity to noxious stimuli PAIN ASSESSMENT Case study • With careful questioning Mr. S indicates that he has two different pains. One has been going on for weeks, is in the right chest, dull, aching and mostly bothers him at night making it difficult to sleep. He also has sharp, fleeting but intense left chest pain when he coughs or takes a deep breath. This started yesterday after a coughing episode. You explain that both the pneumonia and the cancer in his right lung along with a fluid collection around the lung may cause some of his dull aching pain but you want to get a chest X-ray and suspect a rib fracture related to the coughing and cancer that has spread to his ribs may be causing the more intermittent and intense pain. Pain Assessment • Pain History – – – – – Location Duration Frequency Intensity Quality • Scales – – – – Visual analog scale Numeric rating scales Pain thermometer Facial pain scale Pain Assessment in Advanced Dementia Scale (PAINAD) Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc. 2003;4(1):9-15. Pain Assessment Checklist for Seniors with Limited Ability to Communicate-II (PACSLAC-II) Facial Expressions 1. Grimacing 2. Tighter face 3. Pain expression 4. Increased eye movement 5. Wincing 6. Opening mouth 7. Creasing forehead 8. Lowered eyebrows or frowning 9. Raised cheeks, narrowing of the eyes or squinting 10. Wrinkled nose and raised upper lip 11. Eyes closing Verbalizations and Vocalizations 12. Crying 13. A specific sound for pain (e.g., ‘ow’, ‘ouch’) 14. Moaning and groaning 15. Grunting 16. Gasping or breathing loudly Body Movements 17. Flinching or pulling away 18. Thrashing 19. Refusing to move 20. Moving slow 21. Guarding sore area 22. Rubbing or holding sore area 23. Limping 24. Clenched fist 25. Going into foetal position 26. Stiff or rigid 27. Shaking or trembling Changes in Interpersonal Interactions 28. Not wanting to be touched 29. Not allowing people near Changes in Activity Patterns or Routines 30. Decreased activity Mental Status Changes 31. Are there mental status changes that are due to pain and are not explained by another condition (e.g., delirium due to medication, etc.)? Case Study - After talking with Mr. S for a while you explain that you are concerned about his discomfort and feel that it should be treated with medication. You explain the 0 to 10 numeric pain scale and ask him to rate his current level of discomfort. - You also explain that the nurses will be administering acetaminophen regularly but that you will also provide a medication that is stronger that he can ask for when his pain is not adequately controlled with the scheduled medication. They will be asking him to use the pain scale so that you can monitor how well the medication is working and know how to make adjustments. - You also ask if you can arrange for a chaplain to come and speak with Mr. S since he is still adjusting to the implications of this new diagnosis on his quality and length of life. Physician role in pain assessment • • • • • • Historical context Physical examination Developing a differential diagnosis Establishing a working diagnosis Determining a treatment plan Availability for follow up and readjustment of the plan based on continued assessment of response Pitfalls to be Avoided by Providers • Reporting by staff may be – Superficial – Without sufficient chronology – Lacking reports of response to treatment • Patients, families and staff may request specific interventions that may not be the most appropriate response • Chronic pain necessitates pain relief goals that include functional targets rather than intensity scale targets alone Ballantyne JC & Sullivan MD. NEJM 2015;373(22):2098-99 NONPHARMACOLOGIC APPROACHES Transcutaneous Electrical Nerve Stimulation (TENS) Condition Evidence Outcomes Comment Back Pain Small RCTs** Conflicting Against PHN* Case reports one RCT Positive Insufficient PDN* Small RCTs Positive For *PHN: Postherpetic Neuralgia; PDN: Painful Diabetic Neuropathy **RCTs: Randomized Controlled Trials Dubinsky et al. Neurology 2010;74;173-176 Khadilkar A et al. Cochrane Collaboration, 2008, DOI: 10.1002/14651858.CD003008.pub3 Acupuncture Condition Evidence Outcomes Back Pain Meta-Analysis Positive For PHN Case reports Insufficient OA* Meta-Analysis Positive Positive Comment For *OA: Osteoarthritis Vickers AJ et al. Archives of Internal Medicine. 2012;172:1444-53 Furlan AD et al. Cochrane Collaboration, 2005 DOI: 10.1002/14651858.CD001351.pub2 Manheimer E Cochrane Collaboration, 2010 DOI: 10.1002/14651858.CD001977.pub2 Percutaneous Electrical Nerve Stimulation (PENS) Condition Evidence Outcomes Comment Back Pain Small RCTs Positive Consider PHN with myofascial pain Case Reports Positive Consider Weiner DK et al. Pain 2008;140:344-57. Weiner DK & Schmader KE. Pain Med 2006;7(3):243-9 Cognitive Behavioral Therapy* Condition Evidence Outcomes Comment Back Pain Meta-analysis Positive For PHN None N/A Insufficient Arthritis Meta-analysis Positive For *Patients attend 6–12 sessions to learn and practice pain-management skills, including relaxation, distraction, activity pacing, cognitive restructuring, problem solving Keefe FJ et al. Br J Anaesthesia 2013;111:89–94 Dixon KE et al. J Pain Sympt Manage 2007;26:241–50 Hoffman BM et al. Health Psychol 2007;26:1–9 Eccleston C, et al. Cochrane Collaboration 2009; CD007407. Cipher DJ, et al. Clin Gerontol 2007;30:23–40. Cook AJ. J Gerontol B Psychol Sci Soc Sci 1998;53:51–9. Tried and true… • • • • • • Distraction Relaxation Heat/Cold Repositioning Rest/Pacing activities Muscle strengthening • • • • • Getting restful sleep Physical therapy Chiropractic care Self management Avoiding postures and positions that provoke pain PHARMACOLOGIC APPROACHES Pharmacologic Changes with Aging Concern Normal Aging Common Disease Effects GI Slowing of transit (i.e., Enhanced dysmotility with opioids) Surgical alterations reduce absorption Distribution Increased fat to lean increases volume of distribution fat soluble drugs (i.e., diazepam) Obesity longer effects of drugs Liver metabolism Oxidation may decrease and increase drug half life Cirrhosis, hepatitis, tumors may disrupt oxidation, Renal excretion Reduced GFR leads to decreased excretion Chronic kidney disease exacerbates Active metabolites Reduced GFR prolongs effects of metabolites Chronic kidney disease increases half life Anticholinergic effects Multiple age related changes lead to greater sensitivity to confusion, constipation, incontinence, movement disorders Enhanced by neurological disease Topical Therapies for Chronic Pain in Older Adults Condition Topical NSAIDs Capsaicin Lidocaine Patch Back Pain No trials Off Label Post Herpetic Case reports Neuralgia Off Label Osteoarthritis Positive RCTs FDA Label No trials Off Label Case reports, small trials Off Label RCTs FDA Label (8% patch) Positive RCTs FDA Label Positive RCTs FDA Label Case reports, small trials Off Label RCT- Randomized Controlled Trials Derry S. Cochrane Collaboration 2012;9:CD010111. doi: 10.1002/14651858.CD010111. Derry S. Cochrane Collaboration 2013;2:CD007393. doi: 10.1002/14651858.CD007393.pub3 Acetaminophen • First line therapy for mild to moderate musculoskeletal pain • Better safety profile than NSAIDs • Randomized controlled trials confirm acetaminophen is effective for musculoskeletal pain, equal to and sometimes superior to NSAIDs in many patients • Often greater effectiveness with scheduled dosing • Extended release preparation may decrease pill burden • Maximum dose to avoid hepatic toxicity 4000mg/24 hours *AGS Panel on Pharmacological Management of Persistent Pain, JAGS 2009;57:1331-1346 **British Geriatrics Society Guidance on the Management of Pain in Older People, Age and Ageing 2013;42:i1–i57 Adjust Acetaminophen Dosing in Older Adults at Risk for Hepatotoxicity • Reduce maximum dose 50% to 75% in patients with – Hepatic insufficiency – Alcohol abuse – Malnutrition – Concomitant use of enzyme-inducing drugs e.g., carbamazepine, phenytoin, barbiturates, AGS Guidelines, JAGS 2009;57:1331-1346 British Geriatrics Society Guidelines, Age and Ageing 2013;42:i1–i57 Acetaminophen Special Uses Type Scheduled oral Intravenous Oral non-fixed combination with opioids Patients Dementia with behavioral disturbances Surgical patients in perioperative period Moderate to severe pain Husebo BS et al. BMJ 2011;343:d4065 Apfel CC et al. Pain 2013;154:677–689 Outcome Reduced agitation Reduced pain, nausea and vomiting Greater analgesic effect than APAP or higher doses of the opiate alone Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Congestive Heart Failure Peptic Ulcer Disease Chronic Kidney Disease Non-Steroidal Anti-Inflammatory Drugs • More appropriate for acute pain management • Selective use in persistent pain • Topical NSAIDs (↓ systemic levels) may be safer but no long-term studies Mitigate the Risk of GI Bleeding from NSAIDs • Proton pump inhibitor use for individuals at risk for GI bleeding – Medical conditions, e.g., peptic ulcer disease – Antiplatelet agents, Corticosteroids, Warfarin • Eradication of Helicobacter pylori • Consider use of non-acetylated salicylates, e.g., Salsalate – Safer choice for GI bleed risk AGS Panel on Pharmacological Management of Persistent Pain, JAGS 2009;57:1331-1346 Opioids • Moderate to severe acute or chronic pain – significant effect on function and quality of life • Selections depends on… – severity, location, and causes of pain – expected duration of the pain syndrome (acute versus chronic) – desired duration of drug activity – route of administration – adverse effect profile Opioids Selection Adverse Effects • • Constipation (need stimulant laxatives, not bulk-forming) • Nausea and vomiting • Sedation • Psychomotor and cognitive impairment, delirium • Pruritis • Urinary retention • Respiratory Depression (usually preceded by sedation) • At high dose, myoclonus and hallucinations • • Weak Full Agonists • Codeine • Hydrocodone Weak Agonist/Reuptake Inhibitor • Tramadol • Tapentadol Strong Full Agonist • Morphine • Oxycodone • Hydromorphone • Fentanyl • Methadone • Oxymorphone Opioid Risk • Side effects are common – Nausea, sedation, constipation, urinary retention, sweating • Addiction – Low for older adults when treating chronic pain – Exceedingly low (<1%) when treating acute pain – Personal history of substance abuse, family history of substance abuse, younger age, mental illness, preteen sexual abuse increase risk – Physical dependence • Over Treatment • Overdose – at high doses – when combined w/ other sedatives – Illness may effect clearance Monitoring Opioids General • Effectiveness • Adherence • Diversion Adverse Effects • Time is your ally: tolerance develops to many side effects: not to constipation • Multimodal therapy (non-drug therapies, combining drugs that work by different mechanisms) • Dose reduction or route change • Opioid rotation: side effects may be less with one drug than another • Symptom management Are Opioids the answer for chronic pain? • Systematic reviews have not found sufficient evidence that long-term opioid use controls non-cancer pain more effectively than other treatments • when risks outweigh benefits, as will often be the case for chronic pain, opioid use should be avoided in favor of other treatments • the risk of opioids stems primarily from these drugs, not from patients CDC Guidelines for Chronic Pain Benefits out way Risks/Multimodal Treatment Plan Establish Pain and Function Goals Shared Decision-Making and Responsibility CDC Guidelines for Chronic Pain Start with immediate release opioids Use the lowest effective dose Prescribe short courses for acute pain Re-evaluate early and routinely CDC Guidelines for Chronic Pain EVALUATE Risks for HARM Review the history of opioid use Urine drug screening Avoid Benozodiazapines Offer treatment for Opioid Use Disorder TREATMENT PLAN Prescribing Principles • Start low and go slow… – BUT monitor frequently • Increase in gradual increments • Combine medications so doses can be decreased minimizing side effects “rational polypharmacy” • Choose agents that work on different points for additive or synergistic results • Use Scheduled pain medications rather than prn especially for patient who are unable or unwilling to ask for medication • Follow up and Reassess Rational Polypharmacy: Exploiting Synergism N Engl J Med. 2005 Mar 31;352(13):1324-34. Provider Pitfalls in Pain Treatment • Overemphasis on under-treatment of pain in the nursing home can lead to – Excessive treatment of pain that replaces pain with adverse effects – Nonspecific treatment without consideration of the type or severity of pain – Inappropriate treatment (e.g., opioids for chronic abdominal pain) • Patients new to long-term care need to have their pain regimen reassessed • If a medication is not providing any significant pain relief, a higher dose may not be the best answer • Older adults change over time; they may require less pain medication as their function and physical activity decline Interdisciplinary team Pain assessment and management includes all members of the IDT • Physician/Advanced Practice Provider • Licensed nurses • Nurse aides • Therapist-physical, occupational, speech • Nutritionist • Pharmacist Common Pitfalls • Inadequate recognition – Pain behaviors – Adverse effects of medication • Communication – Delays in provider notification – Delays in provider response – Dissemination of plan to the team • Medication procurement – Delays due to lack of a written prescription – Delays due to formulary issues – Delays due to allergy resolution Buhr GT. White HK. Quality improvement initiative for chronic pain assessment and management in the nursing home: a pilot study. J Am Med Dir Assoc 2006;7(4):246- Case Study - It will take time to gather more history about the location, quality, frequency and intensity of Mr. S’s pain. He may have more than one type of pain. It may require additional diagnostic testing to determine the etiology of his pain and the interventions that may help to alleviate it. - For example, X-rays may reveal bone metastases that would be amenable to radiation. The physician should include the patient, nurses, therapists and family in a collaborative plan of care. In addition to an array of pharmacologic and non-pharmacologic interventions, it will be important to outline the plan for continued assessment both by the nursing staff and you to determine response to these interventions and make further adjustments. Resources www.geriatricpain.org The Geriatric Pain website was created to provide nurses who work in long-term care environments with access to free best-practice pain assessment tools and resources to help manage pain in older adults, including quality improvement processes focused on pain management. The web site is made possible by generous funding from The Mayday Fund. Additional support was provided by The University of Iowa, Golden Living and in part by a grant from the RWJ Executive Nurse Fellows program http://www.americangeriatrics.org/health_care_professionals/clinical_practice/clinic al_guidelines_recommendations/2009/ AGS Clinical Practice Guideline: Pharmacological Management of Persistent Pain in Older Persons (2009) Consultant Pharmacist—Utilizing your pharmacist can be a effective way of engaging the team in pain assessment and management. AMDA Pain Management in the Long Term Care Setting Clinical Practice Guideline– This guideline provides the framework for a team approach in nursing facilities References Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc 2003;4(1):9-15 Chan S et al. Evidence-based development and initial validation of the Pain Assessment Checklist for Seniors with Limited Ability to Communicate-II (PACSLAC-II). The Clinical Journal of Pain 2014;30(9):816-24 Ballantyne JC & Sullivan MD. NEJM 2015;373(22):2098-99 Dubinsky et al. Neurology 2010;74;173-176 Khadilkar A et al. Cochrane Collaboration, 2008, DOI: 10.1002/14651858.CD003008.pub3 Vickers AJ et al. Archives of Internal Medicine. 2012;172:1444-53 Furlan AD et al. Cochrane Collaboration, 2005 DOI: 10.1002/14651858.CD001351.pub2 Manheimer E Cochrane Collaboration, 2010 DOI: 10.1002/14651858.CD001977.pub2 Weiner DK et al. Pain 2008;140:344-57. Weiner DK & Schmader KE. Pain Med 2006;7(3):243-9 Keefe FJ et al. Br J Anaesthesia 2013;111:89–94 Dixon KE et al. J Pain Sympt Manage 2007;26:241–50 References Hoffman BM et al. Health Psychol 2007;26:1–9 Eccleston C, et al. Cochrane Collaboration 2009; CD007407. Cipher DJ, et al. Clin Gerontol 2007;30:23–40. Cook AJ. J Gerontol B Psychol Sci Soc Sci 1998;53:51–9. Derry S. Cochrane Collaboration 2012;9:CD010111. doi: 10.1002/14651858.CD010111. Derry S. Cochrane Collaboration 2013;2:CD007393. doi: 10.1002/14651858.CD007393.pub3 Dowell D, et al. Opioid analgesics: risky drugs not risky patients. JAMA 2013; 309(21); 2219-20. Chou R, et al. The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain. Ann Intern Med 2015;162(4):276-86. AGS Panel on Pharmacological Management of Persistent Pain, JAGS 2009;57:1331-1346 British Geriatrics Society Guidance on the Management of Pain in Older People, Age and Ageing 2013;42:i1–i57 Husebo BS et al. BMJ 2011;343:d4065 Apfel CC et al. Pain 2013;154:677–689 N Engl J Med. 2005 Mar 31;352(13):1324-34. Buhr GT. White HK. Quality improvement initiative for chronic pain assessment and management in the nursing home: a pilot study. J Am Med Dir Assoc 2006;7(4):246-53. Post-Test • Same as pretest